ReShape Lifesciences Shares Are Trading Higher After the Company Announced That It Received a Notice of Allowance for Its U.S. Patent Application 17/572,387 Titled "INTRAGASTRIC DEVICE (FOR TREATING OBESITY)"
ReShape Lifesciences宣佈收到一項名爲 “INTRAGASTRIC設備（用於治療肥胖）” 的美國專利申請的批准通知後，該公司股價走高